https://www.selleckchem.com/pr....oducts/rhapontigenin
85 (95%CI 4.73 to 4.97) in women versus 3.89 (95% CI 3.80 to 3.98) in men when AF developed after HF. Compared with rate control for AF, a rhythm-controlling strategy was associated with lowered mortality in inverse probability-weighted models across all strata and in both sexes (hazard ratios 0.75 to 0.83), except for women who developed AF after HF onset (hazard ratio 1.03). More than half of all men and women with HF will develop AF during their clinical course, with prognosis associated with AF being worse in women than men. F
Like
Comment
Share
